HOME >> MEDICINE >> NEWS
Prostate cancer treatment increases risk of diabetes and heart disease

BOSTON -- A treatment mainstay for prostate cancer puts men at increased risk for diabetes and cardiovascular disease, according to a large observational study published in the Sept. 20 Journal of Clinical Oncology.

"Men with prostate cancer have high five-year survival rates, but they also have higher rates of non-cancer mortality than healthy men," says study author Nancy Keating, MD, MPH, assistant professor of health care policy and of medicine at Harvard Medical School. "This study shows that a common hormonal treatment for prostate cancer may put men at significant risk for other serious diseases. Patients and physicians need to be aware of the elevated risk as they make treatment decisions."

The principal systemic therapy for prostate cancer involves blocking testosterone production. This is done either by removal of the testes (bilateral orchiectomy), or more commonly, by regular injections of a gonadotropin-releasing hormone (GnRH) agonist drug. GnRH agonists are the main therapy for metastatic prostate cancer and may also improve survival for some men with locally-advanced cancers.

However, little is known about the efficacy of GnRH agonists in treating men with less-advanced local or regional prostate cancer, many of whom receive this therapy. Earlier studies have found GnRH agonists to be associated with obesity and insulin resistance, a precursor to diabetes.

"Our study found that men with local or regional prostate cancer receiving a GnRH agonist had a 44 percent higher risk of developing diabetes and a 16 percent higher risk of developing coronary heart disease than men who were not receiving hormone therapy," says Keating, who is also a physician at Brigham and Women's Hospital.

"Doctors should think twice about prescribing GnRH agonists in situations for which studies have not demonstrated improved survival until we better understand the risks of treatment," says co-author Matthew Smith, MD, PhD
'"/>

Contact: Leah Gourley
public_affairs@hms.harvard.edu
617-432-0442
Harvard Medical School
18-Sep-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer research may be faster with PSA endpoints
3. Prostate treatment decisions based on perception more than fact
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2019)... ... ... A Place at Home has received the 2019 Best of ... Choice Award is granted only to the top-ranking home care providers, based on caregiver ... care. A Place at Home is ranked among the best employers of in-home caregivers ...
(Date:2/13/2019)... MESA, Calif. (PRWEB) , ... February 13, 2019 , ... ... healthcare scholarship. Open to students who choose to pursue a medical-related course of study ... describe their passion for substance abuse disorder and mental health treatment, and how it ...
(Date:2/13/2019)... ... February 13, 2019 , ... Dr. Christie Prendergast, ... Beauty network. , The Haute Beauty Network, well known for their exclusivity, ... Aesthetic surgeon and our newest addition to the Haute Living partnership. , ...
(Date:2/12/2019)... ... 12, 2019 , ... A technology company that aims to ... won the top award at the 9th annual SPIE Startup Challenge at Photonics ... pitch, nabbing a combined first prize of $15,000. Radiance 4D’s revolutionary 3D printing ...
(Date:2/12/2019)... ... February 12, 2019 , ... ... Solution to increase patient satisfaction, improve patient retention, and reduce patient outmigration for ... February 11-14. HIMSS provides Surgical Theater with a great venue to highlight ...
Breaking Medicine News(10 mins):
(Date:2/13/2019)... VEGAS (PRWEB) , ... February 13, 2019 , ... ... program in Bogotá, Colombia. The new program opens possibilities for childless couples who ... , Until now, childless couples have been limited to North America or ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... the Public Private Partnership (PPP) between the Department of Health-Abu Dhabi (DoH) and ... first Health Information Exchange system (HIE), a centralized platform to streamline healthcare connectivity ...
(Date:2/13/2019)... ... February 13, 2019 , ... ... Thin Clients at HIMSS 2019 US in Orlando, Florida. The compact Thin Clients ... prices of $199 and $520 and above respectively. , Powered by Intel® ...
Breaking Medicine Technology:
Cached News: